Tumor necrosis factor-alpha-activated cell death pathways in NIT-1 insulinoma cells and primary pancreatic beta cells

L A Stephens1, H E Thomas, L Ming

  • 1The Walter and Eliza Hall Institute of Medical Research, Post Office Royal Melbourne Hospital, Parkville, Victoria, Australia.

Endocrinology
|June 29, 1999
PubMed

Insights

Tumor necrosis factor-alpha (TNFalpha) can trigger beta cell death pathways relevant to type 1 diabetes. While TNFalpha alone induces apoptosis in insulinoma cells, primary beta cells require interferon-gamma for this response.

Area of Science:

  • Immunology
  • Endocrinology
  • Cell Biology

Background:

  • Insulin-dependent diabetes mellitus (IDDM) involves beta cell destruction.
  • Tumor necrosis factor-alpha (TNFalpha) is implicated as a mediator in this process.
  • Understanding TNFalpha-induced apoptosis in beta cells is crucial for IDDM research.

Purpose of the Study:

  • To investigate TNFalpha-responsive pathways leading to apoptosis in beta cells.
  • To characterize TNF receptor expression and function in primary beta cells and insulinoma cells.
  • To elucidate the mechanisms of TNFalpha-induced beta cell death.

Main Methods:

  • Flow cytometry and RT-PCR to detect TNF receptor (TNFR1, TNFR2) expression on primary beta cells and NIT-1 insulinoma cells.
  • Assessment of NF-kappaB activation in response to TNFalpha.
  • Induction of apoptosis in beta cells using TNFalpha, interferon-gamma (IFNgamma), and dominant-negative FADD (dnFADD).
  • Caspase activity assays.

Main Results:

  • Primary beta cells express TNFR1 but not TNFR2; NIT-1 cells express TNFR1 at higher levels.
  • TNFalpha activates NF-kappaB in both cell types.
  • TNFalpha induces apoptosis in NIT-1 cells, which can be blocked by dnFADD.
  • Apoptosis of primary beta cells requires both TNFalpha and IFNgamma.
  • IFNgamma enhances TNFalpha-induced apoptosis in NIT-1 cells and increases caspase 1 expression.

Conclusions:

  • TNFalpha-activated apoptotic pathways exist in beta cells.
  • Caspase activation is a key mechanism in TNFalpha-induced NIT-1 cell death.
  • These pathways may contribute to beta cell damage in type 1 diabetes.

Related Concept Videos

Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Acute Pancreatitis II: Pathophysiology01:21

Acute Pancreatitis II: Pathophysiology

The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...